At a glance
ClinicalIndex Comparison RecordN/ACompleted· 280 enrolled
Drug / intervention
nelfilcon A contact lens, modified inversion indicator +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Validation of the New Print on Focus DAILIES Toric
In Brief
A clinical study evaluating nelfilcon A contact lens, modified inversion indicator, nelfilcon A contact lens, no inversion indicator, and 1 other intervention for Myopia. Completed, enrolled 280 participants.
Detailed Summary
The purpose of this study is to validate the improvements to the inversion indicator.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
First PostedApr 2010
Primary CompletionMay 2010
TodayJul 2026
First PostedApr 2, 2010
Enrollment StartMar 1, 2010
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.3 years ago
Interventions
nelfilcon A contact lens, modified inversion indicatordevice
Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with modified inversion indicator
nelfilcon A contact lens, no inversion indicatordevice
Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with no inversion indicator
nelfilcon A contact lens, inversion indicatordevice
Commercially marketed, nelfilcon A, toric, soft contact lens for daily disposable wear, with inversion indicator